Prostate cancer remains a significant health concern, affecting approximately 1 in 8 men, according to Dr. Phillip Koo, Executive Vice President and Chief Medical Officer at the Prostate Cancer Foundation. Early detection through screening is critical, and the traditional PSA blood test has been a cornerstone for decades. However, a more advanced imaging technique, PSMA PET scanning, is emerging as a crucial tool in determining the extent of the disease, which directly influences treatment decisions.
In a recent discussion, Dr. Koo, along with Bill, a prostate cancer patient advocate who has lived with the disease for 18 years, answered common questions about PSMA testing. PSMA, or prostate-specific membrane antigen, is a protein found on the surface of most prostate cancer cells. In over 80 to 90% of cases, this biomarker is expressed, making it a reliable target for imaging. By using a PSMA PET scan, doctors can visualize whether cancer has spread beyond the prostate, providing essential information for staging and guiding therapy.
Bill shared his personal journey, emphasizing the importance of being proactive. After his diagnosis, he sought knowledge and discovered PSMA testing as a potential option. He brought this information to his doctor, and together they decided it would be a valuable part of his treatment plan. Bill described the scan as an empowering experience, giving him clarity about his disease status and enabling him to make informed decisions. He stressed the importance of being an active participant in one's healthcare, noting that "information is power."
Dr. Koo highlighted the collaborative role between patients and physicians in deciding if PSMA testing is appropriate. He encouraged patients to educate themselves and speak up, as this fosters productive conversations with healthcare providers. "Knowing your PSMA status is vitally important to your cancer care," he said.
For those seeking more information, Dr. Koo directs patients to GetYourScan.com, a resource designed to help patients learn about PSMA scans and how to advocate for this important test. This educational initiative, sponsored by Novartis, aims to empower patients to take charge of their prostate cancer journey.
In summary, PSMA testing represents a significant advancement in prostate cancer management, offering precise insights that can lead to tailored treatments. By being informed and proactive, patients can work with their doctors to optimize their care.
